Anti-FBLN3/ EFEMP1/ DHRD functional antibody

Anti-FBLN3/ EFEMP1/ DHRD functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to EFEMP1/EFEMP1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0168-Ab-1/ GM-Tg-hg-SE0168-Ab-2Anti-Human EFEMP1 monoclonal antibodyHuman
GM-Tg-rg-SE0168-Ab-1/ GM-Tg-rg-SE0168-Ab-2Anti-Rat EFEMP1 monoclonal antibodyRat
GM-Tg-mg-SE0168-Ab-1/ GM-Tg-mg-SE0168-Ab-2Anti-Mouse EFEMP1 monoclonal antibodyMouse
GM-Tg-cynog-SE0168-Ab-1/ GM-Tg-cynog-SE0168-Ab-2Anti-Cynomolgus/ Rhesus macaque EFEMP1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0168-Ab-1/ GM-Tg-felg-SE0168-Ab-2Anti-Feline EFEMP1 monoclonal antibodyFeline
GM-Tg-cang-SE0168-Ab-1/ GM-Tg-cang-SE0168-Ab-2Anti-Canine EFEMP1 monoclonal antibodyCanine
GM-Tg-bovg-SE0168-Ab-1/ GM-Tg-bovg-SE0168-Ab-2Anti-Bovine EFEMP1 monoclonal antibodyBovine
GM-Tg-equg-SE0168-Ab-1/ GM-Tg-equg-SE0168-Ab-2Anti-Equine EFEMP1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0168-Ab-1/ GM-Tg-hg-SE0168-Ab-2; GM-Tg-rg-SE0168-Ab-1/ GM-Tg-rg-SE0168-Ab-2;
GM-Tg-mg-SE0168-Ab-1/ GM-Tg-mg-SE0168-Ab-2; GM-Tg-cynog-SE0168-Ab-1/ GM-Tg-cynog-SE0168-Ab-2;
GM-Tg-felg-SE0168-Ab-1/ GM-Tg-felg-SE0168-Ab-2; GM-Tg-cang-SE0168-Ab-1/ GM-Tg-cang-SE0168-Ab-2;
GM-Tg-bovg-SE0168-Ab-1/ GM-Tg-bovg-SE0168-Ab-2; GM-Tg-equg-SE0168-Ab-1/ GM-Tg-equg-SE0168-Ab-2
Products NameAnti-EFEMP1 monoclonal antibody
Formatmab
Target NameEFEMP1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-EFEMP1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0168-Ag-1Recombinant multi-species FBLN3/ EFEMP1/ DHRD protein
    ORF Viral VectorpGMLP002671human EFEMP1 Lentivirus plasmid
    ORF Viral VectorvGMLP002671human EFEMP1 Lentivirus particle
    ORF Viral VectorpGMLPm001084mouse Efemp1 Lentivirus plasmid
    ORF Viral VectorvGMLPm001084mouse Efemp1 Lentivirus particle


    Target information

    Target IDGM-SE0168
    Target NameEFEMP1
    Gene ID2202,216616,305604,718984,474604,101094585,511566,100066175
    Gene Symbol and SynonymsDHRD,DRAD,EFEMP1,FBLN3,FBNL,FIBL-3,MLVT,MTLV,S1-5,T16
    Uniprot AccessionQ12805,O35568
    Uniprot Entry NameFBLN3_HUMAN,FBLN3_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseOsteoarthritis
    Gene EnsemblENSG00000115380
    Target ClassificationN/A

    The target: EFEMP1, gene name: EFEMP1, also named as DHRD, DRAD, FBLN3, FBNL, FIBL-3, MLVT, MTLV, S1-5. This gene encodes a member of the fibulin family of extracellular matrix glycoproteins. Like all members of this family, the encoded protein contains tandemly repeated epidermal growth factor-like repeats followed by a C-terminus fibulin-type domain. This gene is upregulated in malignant gliomas and may play a role in the aggressive nature of these tumors. Mutations in this gene are associated with Doyne honeycomb retinal dystrophy. Alternatively spliced transcript variants that encode the same protein have been described.[provided by RefSeq, Nov 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.